HK Stock Market Move | New China Life Insurance (01336) rises more than 6%, nominates Huang Geng as a candidate for non-executive director, and Central Huijin is the company's largest shareholder.

New China Life Insurance (01336) rose more than 6%, at the time of drafting, it was up 6.56% to HKD 52.05, with a turnover of HKD 476 million. In terms of news, recently, New China Life Insurance announced that, according to the provisions of the Articles of Association of the Company, shareholders holding more than 3% of the voting shares of the Company individually or collectively can nominate non-independent director candidates. As of the date of this announcement, Central Huijin Investment Limited holds 31.34% of the Company's shares and has nominated Huang Geng as a candidate for non-executive director of the Company's ninth board of directors. At the eighth meeting of the ninth board of directors held by the Company on June 10, 2026, the proposal to nominate Mr. Huang Geng as a candidate for non-executive director of the ninth board of directors was approved, and it was agreed to nominate Mr. Huang Geng as a candidate for non-executive director of the ninth board of directors. The above proposal needs to be reviewed by the Company's shareholders' meeting. After the approval of the shareholders' meeting, Mr. Huang Geng's director qualifications still need to be approved by regulatory authorities.